134 related articles for article (PubMed ID: 25317801)
1. Serum and tissue expression of gelatinase and Twist in breast cancer.
Huang J; Ang L; Liu MQ; Hu HG; Wang J; Zou Q; Zhao Y; Zheng L; Zhao M; Wu ZS
Eur Rev Med Pharmacol Sci; 2014; 18(18):2662-9. PubMed ID: 25317801
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer.
Wu ZS; Wu Q; Yang JH; Wang HQ; Ding XD; Yang F; Xu XC
Int J Cancer; 2008 May; 122(9):2050-6. PubMed ID: 18172859
[TBL] [Abstract][Full Text] [Related]
3. Expression of metalloproteinases MMP-2 and MMP-9 in sentinel lymph node and serum of patients with metastatic and non-metastatic breast cancer.
Daniele A; Zito AF; Giannelli G; Divella R; Asselti M; Mazzocca A; Paradiso A; Quaranta M
Anticancer Res; 2010 Sep; 30(9):3521-7. PubMed ID: 20944132
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of matrix metalloproteinase-9 predict lymph node metastasis in breast cancer patients.
Heo DS; Choi H; Yeom MY; Song BJ; Oh SJ
Oncol Rep; 2014 Apr; 31(4):1567-72. PubMed ID: 24481627
[TBL] [Abstract][Full Text] [Related]
5. [Zymography--method for quantitation of activity on gelatinase A (pro-MMP-2, 72 kDa) and gelatinase B (pro-MMP-9, 92 kDa) in serum of patients with breast cancer].
Sliwowska I; KopczyĆski Z
Wiad Lek; 2007; 60(5-6):241-7. PubMed ID: 17966888
[TBL] [Abstract][Full Text] [Related]
6. Expression and correlation of Twist and gelatinases in breast cancer.
Zhao M; Hu HG; Huang J; Zou Q; Wang J; Liu MQ; Zhao Y; Li GZ; Xue S; Wu ZS
Exp Ther Med; 2013 Jul; 6(1):97-100. PubMed ID: 23935727
[TBL] [Abstract][Full Text] [Related]
7. Significance of MMP-9 and VEGF-C expression in North Indian women with breast cancer diagnosis.
Thammineni KL; Thakur GK; Kaur N; Banerjee BD
Mol Cell Biochem; 2019 Jul; 457(1-2):93-103. PubMed ID: 30993496
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of twist and matrix metalloproteinase-9 with metastasis and prognosis in gastric cancer.
Gao XH; Yang XQ; Wang BC; Liu SP; Wang FB
Asian Pac J Cancer Prev; 2013; 14(9):5055-60. PubMed ID: 24175775
[TBL] [Abstract][Full Text] [Related]
9. Significance of TWIST expression and its association with E-cadherin in bladder cancer.
Zhang Z; Xie D; Li X; Wong YC; Xin D; Guan XY; Chua CW; Leung SC; Na Y; Wang X
Hum Pathol; 2007 Apr; 38(4):598-606. PubMed ID: 17258791
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of plasma MMP-2 and MMP-9 levels as biomarkers for tumor expression in breast cancer patients in Egypt.
Alrehaili AA; Gharib AF; Karam RA; Alhakami RA; El Sawy WH; Abd Elrahman TM
Mol Biol Rep; 2020 Feb; 47(2):1153-1160. PubMed ID: 31820313
[TBL] [Abstract][Full Text] [Related]
11. [Expression of matrix metalloproteinase (MMP-2) and extracellular matrix metalloproteinases inducer (EMMPRIN) in benign and advanced breast cancer tissue samples].
Chandru H; Sharada AC; Manjunath S
Biomed Khim; 2007; 53(4):461-7. PubMed ID: 18035727
[TBL] [Abstract][Full Text] [Related]
12. Expression and correlation of matrix metalloproteinase-9 and heparanase in patients with breast cancer.
Tang D; Piao Y; Zhao S; Mu X; Li S; Ma W; Song Y; Wang J; Zhao W; Zhang Q
Med Oncol; 2014 Jul; 31(7):26. PubMed ID: 24861922
[TBL] [Abstract][Full Text] [Related]
13. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.
Pellikainen JM; Ropponen KM; Kataja VV; Kellokoski JK; Eskelinen MJ; Kosma VM
Clin Cancer Res; 2004 Nov; 10(22):7621-8. PubMed ID: 15569994
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of matrix metalloproteinases MMP-2 and MMP-9 and their tissue natural inhibitors in breast tumors.
Jinga D; Stefanescu M; Blidaru A; Condrea I; Pistol G; Matache C
Roum Arch Microbiol Immunol; 2004; 63(3-4):141-58. PubMed ID: 17240786
[TBL] [Abstract][Full Text] [Related]
15. Circulating tumor cells and serum levels of MMP-2, MMP-9 and VEGF as markers of the metastatic process in patients with high risk of metastatic progression.
Skerenova M; Mikulova V; Capoun O; Zima T; Tesarova P
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Sep; 161(3):272-280. PubMed ID: 28529342
[TBL] [Abstract][Full Text] [Related]
16. Role of serum matrix metalloproteinase-2 and -9 to predict breast cancer progression.
Patel S; Sumitra G; Koner BC; Saxena A
Clin Biochem; 2011 Jul; 44(10-11):869-72. PubMed ID: 21565179
[TBL] [Abstract][Full Text] [Related]
17. Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis.
Goldbach-Mansky R; Lee JM; Hoxworth JM; Smith D; Duray P; Schumacher RH; Yarboro CH; Klippel J; Kleiner D; El-Gabalawy HS
Arthritis Res; 2000; 2(2):145-53. PubMed ID: 11062605
[TBL] [Abstract][Full Text] [Related]
18. Zymographic detection and clinical correlations of MMP-2 and MMP-9 in breast cancer sera.
La Rocca G; Pucci-Minafra I; Marrazzo A; Taormina P; Minafra S
Br J Cancer; 2004 Apr; 90(7):1414-21. PubMed ID: 15054465
[TBL] [Abstract][Full Text] [Related]
19. Expression of matrix metalloproteinases 2, 7 and 9 in patients with colorectal cancer.
Kostova E; Slaninka-Miceska M; Labacevski N; Jakovski K; Trojachanec J; Atanasovska E; Janevski V; Jovanovik R; Janevska V
Vojnosanit Pregl; 2014 Jan; 71(1):52-9. PubMed ID: 24516991
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of Twist in oesophageal squamous cell carcinoma is associated with neoplastic transformation and distant metastasis.
Yuen HF; Chan YP; Wong ML; Kwok WK; Chan KK; Lee PY; Srivastava G; Law SY; Wong YC; Wang X; Chan KW
J Clin Pathol; 2007 May; 60(5):510-4. PubMed ID: 16822877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]